Denis Mulleman

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial

Louis Bernard, Aurélien Dinh, Idir Ghout et al. · The Lancet · 2014 · 481 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial

Xavier Chevalier, Philippe Ravaud, E. Maheu et al. · Annals of the Rheumatic Diseases · 2014 · 179 citations

Medicine, Pharmacology, Pharmacotherapy +17

Optimal Duration of Antibiotic Therapy in Vertebral Osteomyelitis

F. Roblot, Jean‐Marc Besnier, L. Juhel et al. · Seminars in Arthritis and Rheumatism · 2007 · 172 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

Rituximab‐Induced T Cell Depletion in Patients With Rheumatoid Arthritis: Association With Clinical Response

J Melet, Denis Mulleman, Philippe Goupille et al. · Arthritis & Rheumatism · 2013 · 162 citations

Life Sciences, Immunology, Internal Medicine +17

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases

Émilie Ducourau, Denis Mulleman, Gilles Paintaud et al. · Arthritis Research & Therapy · 2011 · 158 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17